179 related articles for article (PubMed ID: 37185460)
1. A role for the kidney in metformin action.
Greenhill C
Nat Rev Endocrinol; 2023 Jun; 19(6):313. PubMed ID: 37185460
[No Abstract] [Full Text] [Related]
2. The kidney is a novel target of metformin.
Carney EF
Nat Rev Nephrol; 2023 Jul; 19(7):424. PubMed ID: 37198332
[No Abstract] [Full Text] [Related]
3. Metformin: fifty-two not out.
Campbell IW
J Indian Med Assoc; 2009 Nov; 107(11):779-84. PubMed ID: 20469782
[No Abstract] [Full Text] [Related]
4. Metformin and the Gut Microbiome in Diabetes.
Devaraj S; Venkatachalam A; Chen X
Clin Chem; 2016 Dec; 62(12):1554-1555. PubMed ID: 27650682
[No Abstract] [Full Text] [Related]
5. Mechanisms of metformin action: In and out of the gut.
Minamii T; Nogami M; Ogawa W
J Diabetes Investig; 2018 Jul; 9(4):701-703. PubMed ID: 29777629
[TBL] [Abstract][Full Text] [Related]
6. Metformin: intrinsic vasculoprotective properties.
Wiernsperger NF
Diabetes Technol Ther; 2000; 2(2):259-72. PubMed ID: 11469268
[No Abstract] [Full Text] [Related]
7. Metformin.
Bailey CJ; Turner RC
N Engl J Med; 1996 Feb; 334(9):574-9. PubMed ID: 8569826
[No Abstract] [Full Text] [Related]
8. Metformin in polycystic ovary syndrome.
Fisken RA
N Engl J Med; 2008 Apr; 358(17):1866-7; author reply 1868. PubMed ID: 18437727
[No Abstract] [Full Text] [Related]
9. The mystery of metformin.
Spiering MJ
J Biol Chem; 2019 Apr; 294(17):6689-6691. PubMed ID: 31028160
[No Abstract] [Full Text] [Related]
10. Metformin in polycystic ovary syndrome.
Mascitelli L; Pezzetta F; Goldstein MR
N Engl J Med; 2008 Apr; 358(17):1867-8; author reply 1868. PubMed ID: 18437729
[No Abstract] [Full Text] [Related]
11. Metformin.
Nurs Times; 2005 Oct 4-10; 101(40):37-8. PubMed ID: 16250540
[No Abstract] [Full Text] [Related]
12. [Metformin and type-2 diabetes mellitus].
Mata Cases M
Aten Primaria; 2008 Mar; 40(3):147-53. PubMed ID: 18373928
[No Abstract] [Full Text] [Related]
13. Role of metformin in type II diabetes.
Epstein S
Cleve Clin J Med; 1995; 62(5):278-9. PubMed ID: 7586481
[No Abstract] [Full Text] [Related]
14. Association between pancreatic cancer and metformin use in patients with type 2 diabetes.
Lai SW; Tsai CH; Lin CL; Liao KF
Postgrad Med J; 2019 May; 95(1123):291. PubMed ID: 30975725
[No Abstract] [Full Text] [Related]
15. Metformin: evidence-based versus rational pharmacotherapy.
Smits P; Tack CJ
Neth J Med; 2002 Jul; 60(6):228-30. PubMed ID: 12365465
[No Abstract] [Full Text] [Related]
16. Significance of Metformin Use in Diabetic Kidney Disease.
Kawanami D; Takashi Y; Tanabe M
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545901
[TBL] [Abstract][Full Text] [Related]
17. Metformin: an antihyperglycemic drug for non-insulin-dependent diabetes mellitus.
Kupecz D
Nurse Pract; 1995 Jul; 20(7):70-2. PubMed ID: 7675343
[No Abstract] [Full Text] [Related]
18. In brief: New recommendations for use of metformin in renal impairment.
Med Lett Drugs Ther; 2016 Apr; 58(1493):51. PubMed ID: 27101208
[No Abstract] [Full Text] [Related]
19. Summaries for patients. Metformin for patients with type 2 diabetes mellitus.
Ann Intern Med; 2002 Jul; 137(1):I50. PubMed ID: 12093266
[No Abstract] [Full Text] [Related]
20. Metformin and the intestine.
Bailey CJ; Wilcock C; Scarpello JH
Diabetologia; 2008 Aug; 51(8):1552-3. PubMed ID: 18528677
[No Abstract] [Full Text] [Related]
[Next] [New Search]
